TickerHumSide-by-side comparison
Amgen vs Pfizer
As of Nov 11, 2026, P/E is 27.1x for Amgen vs 42.1x for Pfizer; P/S is 6.5x for Amgen vs 2.6x for Pfizer; revenue growth is 8.2% for Amgen vs 1.3% for Pfizer; net margin is 24.1% for Amgen vs 6.3% for Pfizer.
What stands out
- Amgen is cheaper on earnings: 27.1x P/E vs 42.1x for Pfizer.
- Pfizer carries less debt relative to equity: 0.67 vs 3.60 for Amgen.
- Amgen scores higher on TickerHum's ratings: 69/100 vs 52/100 for Pfizer.
Key metrics
| Metric | AMGN | PFE |
|---|---|---|
| Price | $468.11 | $29.45 |
| Market cap | $253.21B | $167.86B |
| P/E | 27.1x (#1) | 42.1x (#2) |
| P/S | 6.5x (#2) | 2.6x (#1) |
| Revenue growth | 8.2% (#1) | 1.3% (#2) |
| Operating margin | 32.4% (#1) | — |
| Net margin | 24.1% (#1) | 6.3% (#2) |
| Debt / equity | 3.60 (#2) | 0.67 (#1) |
| 1-year return | — | — |
| Research score | 69/100 (#1) | 52/100 (#2) |
Higher is better for growth, margins, one-year return and overall score; lower is better for valuation and debt ratios. Ties share a rank and missing values are excluded.
Company research
- Amgen Inc. (AMGN) — Drug Manufacturers—General
- Pfizer Inc. (PFE) — Drug Manufacturers—General